(MDNA) – FDA
-
Medicenna Therapeutics (MDNA) Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study
-
Medicenna Therapeutics (MDNA) Presents Updated Preclinical Data on MDNA113
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MDNA Stock Lookup